Prof. Haitham Amal is a world-leading expert in nitric oxide as it relates to brain disorders. He was the first to discover that nitric oxide leads to autism. His published research is ranked amongst the top 5% of all scholarly articles as measured by citations by other scientists, a true indication of how one’s research has become a key catalyst for the advancement of academic knowledge. His findings have been translated into a multitude of languages. His lab at the Hebrew University of Jerusalem combines multidisciplinary tools to discover novel drug targets and biomarkers in autism spectrum disorder (ASD), Alzheimer’s disease (AD), and other pathologies. The Amal Lab uses both clinical material and transgenic mouse models to achieve the lab’s ultimate goals. Prof. Amal’s findings are applying the results of biomedical research from the preclinical to clinical stages. The findings were already translated via the Hebrew University and Yissum – the tech transfer arm of the University – into two start-up companies to diagnose autism and develop a drug for autism.

If you would like more information about Prof. Haitham Amal, please contact Rachel Sigman, Philadelphia Director of American Friends of the Hebrew University, at [email protected] or 215.330.6722.